SecBot SecBot
3 ·Filed Oct 14, 2026
IA

IAM

Iambic Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 22h ago SEC0001864141-26-000005
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Standard Form 3 filing for a new Section 16 officer. No trading signal. Monitor future Form 4 filings for any open-market purchases or sales by the CMO.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d ⚠ clustered
IAM ▼ -22.42% at T+5d
NEUTRAL call -22.42% · α vs SPY -21.41% · entry $18.91 → $14.67
Next anchor: T+20d in 16d
Entry = T+0 close
Oct 14, 2026
via day close
T+1d
+25.91%
call +25.91% · α +27.02%
$23.81
settled 11d ago
T+5d
-22.42%
call -22.42% · α -21.41%
$14.67
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Form 3 initial beneficial ownership filing for Neil Josephson, newly appointed Chief Medical Officer of Iambic Therapeutics. Reports 40,459 shares of common stock and two tranches of employee stock options (175,533 shares at $4.95, 57048 shares at $8.73). Routine insider onboarding filing with no material financial impact.

Key Facts

  • Neil Josephson appointed Chief Medical Officer of Iambic Therapeutics
  • Reports beneficial ownership of 40,459 shares of common stock
  • Holds options to purchase 175,533 shares at $4.95 (expiring 2034-02-16) and 57,048 shares at $8.73 (expiring 2036-03-03)
  • Filing is a routine initial statement of ownership under Section 16

Financial Impact

No financial impact — routine insider onboarding filing

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001864141-26-000005
Document: 0001864141-26-000005-index-headers.html0001864141-26-000005
Document: 0001864141-26-000005-index.html0001864141-26-000005
Document: 0001864141-26-000005.txt0001864141-26-000005
11 reports for IAM
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IAM — sortable, filterable
TypeNow
Oct 19, 2026
6d ago
Insider Buy
BULLISH ★ 6/10
$16.01 $15.80▼ −1.31%▼ −1.84%$14.41 (−9.99%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$16.34 $16.01▼ −2.02%▼ −2.35%$14.41 (−11.81%)
Oct 15, 2026
11d ago
424B4
NEUTRAL ★ 6/10
$23.81 $16.34▼ −31.37%▼ −31.80%$14.41 (−39.48%)
Oct 15, 2026
11d ago
EFFECT
BULLISH ★ 7/10
$18.91 $23.81▲ +25.91%▲ +27.02%$14.41 (−23.80%)
Oct 14, 2026
11d ago
3
NEUTRAL ★ 2/10
$18.91 $23.81▲ +25.91%▲ +27.02%$14.41 (−23.80%)
Oct 14, 2026
11d ago
3
NEUTRAL ★ 1/10
$18.91 $23.81▲ +25.91%▲ +27.02%$14.41 (−23.80%)
Oct 14, 2026
11d ago
3
NEUTRAL ★ 2/10
$18.91 $23.81▲ +25.91%▲ +27.02%$14.41 (−23.80%)
Oct 14, 2026
11d ago
3
NEUTRAL ★ 2/10
$18.91 $23.81▲ +25.91%▲ +27.02%$14.41 (−23.80%)
Oct 14, 2026
11d ago
3
NEUTRAL ★ 2/10
$18.91 $23.81▲ +25.91%▲ +27.02%$14.41 (−23.80%)
Oct 14, 2026
11d ago
3
NEUTRAL ★ 2/10
$18.91 $23.81▲ +25.91%▲ +27.02%$14.41 (−23.80%)
Showing 10 of 11

US Market Status

Market Closed — Opens Tue (16h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 14, 2026